US Stock MarketDetailed Quotes
INRX Intrinsic Medicine
- 0.000
- 0.0000.00%
Close Apr 24 09:30 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.000Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)11.29MShares0.00052wk High0.00P/B0Float Cap0.00052wk Low--Dividend TTM4.17MShs Float0.000Historical High--Div YieldTTM0.00%Amplitude0.000Historical Low--Avg Price1Lot Size
Intrinsic Medicine Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|
| Total revenue | 0 | 0 |
| Operating revenue | --0 | --0 |
| Cost of revenue | ||
| Gross profit | ||
| Operating expense | 196.59%3.57M | 1.2M |
| Selling and administrative expenses | 325.19%2.82M | --663K |
| -General and administrative expense | 325.19%2.82M | --663K |
| Research and development costs | 38.40%746K | --539K |
| Operating profit | -196.59%-3.57M | -1.2M |
| Net non-operating interest income expense | -387.89%-1.41M | -289K |
| Non-operating interest expense | 387.89%1.41M | --289K |
| Other net income (expense) | -1,287.28%-6.98M | -503K |
| Gain on sale of security | -1,306.76%-7.08M | ---503K |
| Special income (charges) | --98K | --0 |
| -Less:Other special charges | ---98K | ---- |
| Income before tax | -499.45%-11.95M | -1.99M |
| Income tax | 0 | 0 |
| Net income | -499.45%-11.95M | -1.99M |
| Net income continuous Operations | -499.45%-11.95M | ---1.99M |
| Minority interest income | ||
| Net income attributable to the parent company | -499.45%-11.95M | -1.99M |
| Preferred stock dividends | ||
| Other preferred stock dividends | ||
| Net income attributable to common stockholders | -499.45%-11.95M | -1.99M |
| Basic earnings per share | -331.45%-2.09 | -0.4844 |
| Diluted earnings per share | -331.45%-2.09 | -0.4844 |
| Dividend per share | ||
| Currency Unit | USD | USD |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg